{
    "nctId": "NCT00991263",
    "briefTitle": "Study of Tissue Samples From Women Treated With Paclitaxel for Breast Cancer on Clinical Trial CALGB-9344 or CALGB-9741",
    "officialTitle": "Intrinsic Breast Cancer Subtypes and Benefit of Paclitaxel in CALGB 9344 and Dose Dense Therapy in CALGB 9741",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 3677,
    "primaryOutcomeMeasure": "Disease-free survival (DFS)",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Diagnosis of stage II or IIIA breast cancer\n\n  * Received treatment with paclitaxel on clinical trial CALGB-9344 or CALGB-9741\n* Tissue blocks available\n\nPATIENT CHARACTERISTICS:\n\n* See Disease Characteristics\n* Pre-, peri-, or postmenopausal\n\nPRIOR CONCURRENT THERAPY:\n\n* See Disease Characteristics",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}